02 Sep 2021
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2021/09/02/2291229/19871/en/Supernus-Announces-Qelbree-sNDA-for-Adult-Indication-Accepted-for-Review-by-FDA.html
24 May 2021
// Brian Park, PharmD EMPR
https://www.empr.com/home/news/qelbree-now-available-for-pediatric-adhd/#:~:text=Qelbree%E2%84%A2%20(viloxazine%20extended%2Drelease,inhibiting%20the%20reuptake%20of%20norepinephrine.
LOOKING FOR A SUPPLIER?